EPISODE · Oct 5, 2021 · 6 MIN
Tuesday, October 5, 2021
from The Gist Healthcare Podcast
Merck’s new antiviral pill to treat COVID-19 shows a lot of promise. CMS lays out how the No Surprises Act dispute resolution process will work. And non-covid research is still lagging behind pre-pandemic levels. Hosted on Acast. See acast.com/privacy for more information.
What this episode covers
Merck’s new antiviral pill to treat COVID-19 shows a lot of promise. CMS lays out how the No Surprises Act dispute resolution process will work. And non-covid research is still lagging behind pre-pandemic levels. Hosted on Acast. See acast.com/privacy for more information.
NOW PLAYING
Tuesday, October 5, 2021
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m